« Back
Bioluminescent Assay for GTPases Allows Measurement of GTPase, GAP and GEF Activities
Poster Title: Bioluminescent Assay for GTPases Allows Measurement of GTPase, GAP and GEF Activities
Submitted on 25 May 2017
Author(s): Subhanjan Mondal and Said A. Goueli
Affiliations: Promega Corporation, 2800 Woods Hollow Rd, Madison, WI, 53711
Poster Views: 1,836
View poster »

Poster Information
Abstract: GTPases play a major role in various cellular functions such as cell signaling, cell proliferation, cell differentiation, cytoskeleton modulation and cell motility. Deregulation or mutation of these proteins results in in serious pathological conditions. Targeting GTPases and their regulators have been challenging due to lack of convenient assays. To overcome the challenges in analyzing activities of GTPases and their regulatory proteins GTPase Activating Proteins (GAP) and Guanine Nucleotide Exchange Factors (GEF) we have developed a homogenous bioluminescent assay (GTPase-Glo) system to analyze these proteins in a simple, convenient “add-mix-read” format.

The assay consists of optimized reaction buffers that allow continuous progression of the GTPase cycle and hydrolysis of GTP. The assay relies on enzymatic conversion of GTP remaining after the GTPase reaction to ATP and bioluminescent detection of the ATP. We show that the assay is sensitive and robust when analyzing for analyzing intrinsic GTPase- activity, GAP-stimulated GTPase- activity, GAP- activity and GEF- activity. The assay has minimal false hits when tested for compound interference using the LOPAC library (library of pharmacologically active compounds) indicative of the robustness in identifying small molecule modulators of GTPase using high throughput screening
Summary: • Universal
• Highly sensitive
• Easy to use
• HTS compatible
• Pulldown-based capability using cell lysates
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Plant Extract
Tylor Keller

3D Printing Materials
Tylor Keller

Chemical Fluorescence Probe
Tylor Keller

low-volume workflows improve the quality of drug discovery: two case studies
Margaret Kenney#, Archi Joardar#, Vasudeo Badarinarayana#, Joby Jenkins*

Dissecting the genomic profile of persistently infecting oncolytic Newcastle disease virus (NDVpi) from cancer RNA-Seq data
Ahmad U1, Chan SC2, Chau DM1, Chia SL5, Abdullah S1,3, Yusoff K5 & Veerakumarasivam A1,4*